Perspective

 
 

  • Physicians: Want Streaming Glory? Know These Legal Tips If you are thinking of becoming a YouTuber or podcaster, before you put your reputation on the line, be aware of these important tips from a healthcare attorney.
  • Should You Pursue Certification in Lifestyle Medicine? Yes Lifestyle medicine is only getting bigger, and certified physicians will be highly sought-after, says lifestyle medicine practitioner Cate Collings, MD.
  • Had My Patient Come In Today, We May Have Had Other Options Only around 3% of nonsquamous NSCLC tumors carry HER2 mutations, and they are associated with female sex, never-smokers, and a poor prognosis. Now these patients can be offered a targeted therapy.
  • Highlights in Advanced NSCLC From ESMO 2022   Highlights in NSCLC from ESMO 2022 include sotorasib in KRAS G12C mutated disease, 5-year data on pembrolizumab, and novel treatment combinations in EGFR-mutated tumors, as discussed by Jack West.
  • In Progressive Lung Cancer Second Biopsies May Be the Norm Now With the advent of targeted therapy and new drugs designed specifically to tackle treatment-resistance mutations, rebiopsies have become a necessity for patients with progressive disease.
  • Episode 2: COVID-19 and MS Patients: Where Do We Go From Here?   Agoraphobia, online yoga, pregnancy, and vaccines are all on the table as Drs Anne Cross and Scott Newsome discuss the COVID-19 pandemic and how it affects their patients with multiple sclerosis.
  • Episode 1: In the Busy MS Clinic: Addressing Cognitive Dysfunction   Drs Anne Cross and Lauren Krupp talk about the latest research and their real-life experience identifying and treating cognitive dysfunction in patients with MS in the busy clinic setting.
  • Episode 4: Assessing Cognitive Functioning in Schizophrenia Patients   Drs John Kane and Philip D. Harvey discuss how physicians can assess cognitive functioning in patients with schizophrenia and how to utilize rehabilitation and technology to address it.
  • A Tale of Two Colonoscopies (and Ryan Reynolds' Butt) Are we adequately understanding and communicating risks for harm to our patients?
  • Is Another COVID-19 Booster Really Needed? Do we need to keep vaccinating against COVID-19? If so, for how long? Let's take a look at the numbers.
  • Key Data on Early NSCLC From ESMO 2022   Osimertinib dosing periods, the use of ctDNA to predict recurrence, and the role of air pollution in promoting lung cancer are among the key topics from ESMO Congress 2022 discussed by Dr Jack West.
  • Life Expectancy Shorter in Women With T2D vs Men   Why is life expectancy for women with type 2 diabetes shorter than for men with the disease? Andrew H. Heald, MD, discusses the findings from 10-year of data and possible contributors to the results.
  • The Hunt for N-Acetylcysteine: Medicine or Dietary Supplement? Psychiatrist Dinah Miller notes that the supplement abruptly became difficult to find in 2021 owing to "a cat-and-mouse chase" between manufacturers, advocacy agencies, and the FDA.
  • ESMO's New Focus on Cancer Prevention WebMD's Chief Medical Officer, John Whyte, talks with ESMO Co-chair Fabrice André on the organization's focus on cancer prevention and recent advances in cancer screening and treatment.
  • A Virus Poised to Jump Species to Humans   Researchers show how close we are to another pandemic, and how it will start with zoonotic transmission.
  • The Price We Pay for an MD Medical school has historically been one of the most expensive courses to undertake at university. Where does this leave those who have a passion and calling for medicine but can't afford it?
  • How Anthem Gets Away With Nonpayment and Denials   Dr Robert Glatter and Dr Andrew Fenton join Andrew Selesnick and James Blakeman to discuss a disturbing pattern of nonpayment and denials by the insurer Anthem.
  • Episode 4: Team Effort: Multidisciplinary Approach to Severe Asthma   Drs Wechsler and Jackson discuss their partnerships with nurses, asthma educators, psychologists, speech therapists, and other specialists when diagnosing and treating patients with severe asthma.
  • Episode 3: Non-Clear Cell Renal Cell Carcinoma   Drs Sumanta Pal and Mehmet Asim Bilen discuss the complexities of treating patients with non-clear cell renal carcinoma, the nuances of rare subtypes, and when to use chemotherapy vs immunotherapy.
  • The Catch-22 of the Nursing Shortage Baby boomers are retiring, and nurses are leaving the field for less stressful jobs. Are we in danger of running out of nurses in the hospitals?